Edition:
United Kingdom

Japan Tissue Engineering Co Ltd (7774.T)

7774.T on Tokyo Stock Exchange

1,295JPY
17 Nov 2017
Change (% chg)

¥1 (+0.08%)
Prev Close
¥1,294
Open
¥1,294
Day's High
¥1,302
Day's Low
¥1,263
Volume
76,800
Avg. Vol
60,530
52-wk High
¥1,596
52-wk Low
¥1,118

Latest Key Developments (Source: Significant Developments)

Fujifilm's regenerative medicine unit appears to be on track to generate profit for FY ending March - Nikkei
Friday, 30 Sep 2016 

Nikkei: Japan Tissue Engineering likely will generate an 11 million yen ($108,000) profit in the fiscal year ending in March - Nikkei .Fujifilm's groupwide sales from health care operations are projected to reach 440 billion yen, or about 17% of overall sales, this fiscal year - Nikkei.  Full Article

Japan Tissue Engineering appoints president
Friday, 20 May 2016 

Japan Tissue Engineering Co Ltd <7774.T>: Says it appoints Aiichiro Hiruma as president to replace Yosuke Ozawa .Says the change planned effective on June 23.  Full Article

Japan Tissue Engineering announces change of corporate auditor
Thursday, 14 Apr 2016 

Japan Tissue Engineering Co Ltd:Appoints KPMG AZSA LLC as new corporate auditor, to replace Ernst & Young ShinNihon LLC, effective on June 23.  Full Article

Japan Tissue Engineering to launch new business
Tuesday, 15 Mar 2016 

Japan Tissue Engineering Co Ltd:To launch regeneration medicine products specialization CRO business as new business.  Full Article

Japan Tissue Engineering lowers consolidated full-year outlook for FY 2016
Tuesday, 15 Mar 2016 

Japan Tissue Engineering Co Ltd:Says the company lowered the consolidated full-year outlook for revenue to 1,425 mln yen from 1,734 mln yen for the fiscal year ending March 31, 2016.Sees a decrease of operating profit forecast to a loss of 895 mln yen from a loss of 773 mln yen.Sees a decrease of ordinary profit forecast to a loss of mln 645 yen from a loss of 584 mln yen.Sees a decrease of net profit forecast to a loss of 649 mln yen from a loss of 588 mln yen.Says lower sales volume in core business as main reason for the forecast.  Full Article